OFIX
Orthofix Medical Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.59
+2.24%Year over year
Reported trailing growth
- Revenue
- +3.0%
- EBITDA
- +2388.3%
- EBIT
- +73.3%
- EPS
- +51.6%
- Free cash flow
- —
- Operating cash flow
- -40.5%
Forward estimates
Based on analyst estimates
- Revenue
- +5.2%
- EBITDA
- -65.1%
- EPS
- +39.2%
Three-year CAGR
- Revenue
- +21.3%
- EBITDA
- -14.1%
- EBIT
- +19.1%
- Net income
- +26.8%
- EPS
- +30.9%
- Free cash flow
- +85.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026